Iron Triangle Partners LP
Follow13F filer, CIK 1779763, Cos Cob, CT
Iron Triangle Partners LP reported $908,441,910 across 23 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-14. Its ten largest share positions make up 62.43% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001172661-25-000888
- Period
- 2024-12-31
- Reported value
- $908M
- Holdings
- 23
- Top 10 weight
- 62.43%
- New
- 14
- Sold out
- 16
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| Anew | +596,326 | $80.1M |
| GMEDnew | +844,013 | $69.8M |
| ABBVnew | +374,012 | $66.5M |
| UNHnew | +120,700 | $61.1M |
| BSXnew | +495,009 | $44.2M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ELANexited | -4,263,343 | -$62.6M |
| ILMNexited | -440,000 | -$57.4M |
| THCexited | -308,940 | -$51.3M |
| ACHCexited | -802,151 | -$50.9M |
| OSCRexited | -1,611,909 | -$34.2M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2024
Share positions as resolved from 13F-HR 0001172661-25-000888, largest first. % of portfolio is the value over $857,855,910, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| AAGILENT TECHNOLOGIES INC | 596,326 | $80.1M | 9.34% | new | Timeline | ||
| GMEDGLOBUS MED INC | 844,013 | $69.8M | 8.14% | new | Timeline | ||
| ABBVABBVIE INC | 374,012 | $66.5M | 7.75% | new | Timeline | ||
| UNHUNITEDHEALTH GROUP INC | 120,700 | $61.1M | 7.12% | new | Timeline | ||
| TEVATEVA PHARMACEUTICAL INDS LTD | 2,200,036 | $48.5M | 5.65% | +256,246 | Timeline | ||
| BSXBOSTON SCIENTIFIC CORP | 495,009 | $44.2M | 5.15% | new | Timeline | ||
| NBIXNEUROCRINE BIOSCIENCES INC | 318,195 | $43.4M | 5.06% | new | Timeline | ||
| NVSTENVISTA HOLDINGS CORPORATION | 2,200,000 | $42.4M | 4.95% | +10,631 | Timeline | ||
| PODDINSULET CORP | 154,014 | $40.2M | 4.69% | +44,014 | Timeline | ||
| MMSIMERIT MED SYS INC | 407,022 | $39.4M | 4.59% | +154,022 | Timeline | ||
| ISRGINTUITIVE SURGICAL INC | 75,000 | $39.1M | 4.56% | +2,999 | Timeline | ||
| DVADAVITA INC | 260,424 | $38.9M | 4.54% | new | Timeline | ||
| EXASEXACT SCIENCES CORP | 600,000 | $33.7M | 3.93% | +200,129 | Timeline | ||
| HQYHEALTHEQUITY INC | 335,614 | $32.2M | 3.75% | new | Timeline | ||
| MEDPMEDPACE HLDGS INC | 90,000 | $29.9M | 3.49% | -102,842 | Timeline | ||
| TWSTTWIST BIOSCIENCE CORP | 492,471 | $22.9M | 2.67% | -17,529 | Timeline | ||
| XBISPDR SERIES TRUST | 250,000 | $22.5M | 2.62% | new | Timeline | ||
| GKOSGLAUKOS CORP | 150,000 | $22.5M | 2.62% | -67,674 | Timeline | ||
| CAHCARDINAL HEALTH INC | 186,002 | $22M | 2.56% | new | Timeline | ||
| ARGXARGENX SE | 35,000 | $21.5M | 2.51% | new | Timeline | ||
| WAYWAYSTAR HLDG CORP | 551,893 | $20.3M | 2.36% | new | Timeline | ||
| DOCSDOXIMITY INC | 312,575 | $16.7M | 1.95% | new | Timeline |
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| UNHUNITEDHEALTH GROUP INC COM | call | 100,000 | $50.6M | new |
Sold out in Q4 2024
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| ELANELANCO ANIMAL HEALTH INC | 4,263,343 | $62.6M | shares |
| ILMNILLUMINA INC | 440,000 | $57.4M | shares |
| THCTENET HEALTHCARE CORP | 308,940 | $51.3M | shares |
| ACHCACADIA HEALTHCARE COMPANY IN | 802,151 | $50.9M | shares |
| OSCROSCAR HEALTH INC | 1,611,909 | $34.2M | shares |
| DHRDANAHER CORP DEL | 110,000 | $30.6M | shares |
| AXSMAXSOME THERAPEUTICS INC. | 252,266 | $22.7M | shares |
| GERNGERON CORP | 3,351,000 | $15.2M | shares |
| SNYSANOFI SA | 261,741 | $15.1M | shares |
| BKDBROOKDALE SR LIVING INC | 2,197,578 | $14.9M | shares |
| INSMINSMED INC | 180,000 | $13.1M | shares |
| ACADACADIA PHARMACEUTICALS INC | 750,000 | $11.5M | shares |
| MYGNMYRIAD GENETICS INC | 401,859 | $11M | shares |
| ELANELANCO ANIMAL HEALTH INC | 723,600 | $10.6M | call |
| INDIVIOR PLCINDIVIOR PLC | 845,470 | $8.24M | shares |
| BCAXBICARA THERAPEUTICS INC | 200,000 | $5.09M | shares |
How Q4 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001172661-25-000888 | base | 2025-02-14 | acceptance time not in the bulk data set |